Inventor · disambiguated record
Susan Barnett
Also filed as: BARNETT SUSAN · BARNETT SUSAN W
29 granted patents·31 pending applications·358 citations·filing 1999–2021
96Inventor score
Top patents by PatentIndex Score
60 records- 0198US11058762B2Immunogenic compositions and uses thereofGEALL ANDREW·Filed 2012·Granted Jul 13, 2021·43 cites·21 claims
- 0294US7771979B2Compositions and methods for generating an immune response utilizing alphavirus-based vector systemsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2007·Granted Aug 10, 2010·39 cites·21 claims
- 0394US6602705B1Expression of HIV polypeptides and production of virus-like particlesCHIRON CORP·Filed 1999·Granted Aug 5, 2003·144 cites·39 claims
- 0492US8647864B2Compositions and methods for generating an immune response utilizing alphavirus-based vector systemsPOLO JOHN M·Filed 2010·Granted Feb 11, 2014·18 cites·21 claims
- 0590US7211659B2Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereofCHIRON CORP·Filed 2002·Granted May 1, 2007·23 cites·47 claims
- 0689US8609109B2HIV vaccine formulationsDONNELLY JOHN·Filed 2011·Granted Dec 17, 2013·13 cites·16 claims
- 0786US8263394B2Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides, and uses thereofZUR MEGEDE JAN·Filed 2008·Granted Sep 11, 2012·4 cites·10 claims
- 0885US8133494B2Expression cassettes endcoding HIV-1 south african subtype C modified ENV proteins with deletions in V1 and V2ZUR MEGEDE JAN·Filed 2007·Granted Mar 13, 2012·6 cites·5 claims
- 0984US7811580B2Chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics that are capable of inducing neutralizing antibody responses against cryptic Env epitopesNOVARTIS VACCINES & DIAGNOSTIC·Filed 2003·Granted Oct 12, 2010·9 cites·24 claims
- 1082US7943375B2Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereofNOVARTIS VACCINES & DIAGNOSTIC·Filed 2008·Granted May 17, 2011·3 cites·44 claims
- 1181US8197819B2Env polypeptide complexes and methods of useSRIVASTAVA INDRESH K·Filed 2005·Granted Jun 12, 2012·8 cites·10 claims
- 1281US7282364B2Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereofNOVARTIS VACCINES & DIAGNOSTIC·Filed 2004·Granted Oct 16, 2007·9 cites·46 claims
- 1379US7622125B2Polycistronic HIV vector constructsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2005·Granted Nov 24, 2009·2 cites·32 claims
- 1479US7618642B2Expression cassettes encoding modified human immunodeficiency virus type 1 subtype C envelope glycoproteinsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2001·Granted Nov 17, 2009·6 cites·20 claims
- 1577US8206720B2Fusion proteins comprising CD4 minimal modules and invasin polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutraliziation epitopesMASIGNANI VEGA·Filed 2005·Granted Jun 26, 2012·2 cites·12 claims
- 1676US8541230B2Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereofBARNETT SUSAN W·Filed 2011·Granted Sep 24, 2013·3 cites·44 claims
- 1774US8168418B2Expression of HIV polypeptides and production of virus-like particlesBARNETT SUSAN W·Filed 2010·Granted May 1, 2012·2 cites·14 claims
- 1874US7935805B1Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereofNOVARTIS VACCINES & DIAGNOSTIC·Filed 2000·Granted May 3, 2011·2 cites·51 claims
- 1974US2010092502A1Modified hiv env polypeptidesNOVARTIS VACCINES & DIAGNOSTIC·Filed 2009·Application pending·0 cites
- 2073US7718401B2Expression of HIV polypeptides and production of virus-like particlesNOVARTIS VACCINES & DIAGNOSTIC·Filed 2008·Granted May 18, 2010·0 cites·10 claims
- 2172US2009081254A1Hiv vaccine for mucosal deliveryNOVARTIS VACCINES & DIAGNOSTIC·Filed 2008·Application pending·0 cites
- 2271US2009208530A1HIV polynucleotides and polypeptides derived from Botswana MJ4LIAN YING·Filed 2009·Application pending·0 cites
- 2370US6689879B2Modified HIV Env polypeptidesCHIRON CORP·Filed 1999·Granted Feb 10, 2004·21 cites·5 claims
- 2469US2008095833A1Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides, and uses thereofNOVARTIS VACCINES & DIAGNOSTIC·Filed 2007·Application pending·0 cites
- 2568US8568734B2Method for generating immune responses utilizing nucleic acids encoding fusion proteins comprising CD4 minimal modules and invasin polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopesMASIGNANI VEGA·Filed 2012·Granted Oct 29, 2013·1 cites·13 claims
- 2665US2010316698A1Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereofNOVARTIS VACCINES & DIAGNOSTIC·Filed 2009·Application pending·0 cites
- 2764US2008026071A1Microparticles for delivery of heterologous nucleic acidsO'HAGAN DEREK·Filed 2007·Application pending·0 cites
- 2863US2021290755A1Immunogenic compositions and uses thereofGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2021·Application pending·0 cites
- 2962US9598469B2HIV-1 south african subtype C env proteinsNOVARTIS VACCINES & DIAGNOSTICS INC·Filed 2013·Granted Mar 21, 2017·0 cites·16 claims
- 3062US7662916B2Modified HIV Env polypeptidesNOVARTIS VACCINES & DIAGNOSTIC·Filed 2003·Granted Feb 16, 2010·0 cites·11 claims
- 3162US2008300385A1Covalently-linked complexes of HIV Tat and Env proteinsSHARMA VICTORIA·Filed 2007·Application pending·0 cites
- 3259US8470334B2Method of inducing an antiviral immune response against HIV-1 utilizing chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimeticsBARNETT SUSAN W·Filed 2012·Granted Jun 25, 2013·0 cites·28 claims
- 3359US8173137B2Polycistronic HIV vector constructsMEGEDE JAN ZUR·Filed 2009·Granted May 8, 2012·0 cites·16 claims
- 3459US2009238841A1Hiv vaccine formulationsDONNELLY JOHN·Filed 2009·Application pending·0 cites
- 3559US2005175631A1Hiv vaccine and method of useFiled 2003·Application pending·0 cites
- 3659US2012269840A1Expression of hiv polypeptides and production of virus-like particlesBARNETT SUSAN W·Filed 2012·Application pending·0 cites
- 3758US2011212164A1Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereofNOVARTIS VACCINES & DIAGNOSTIC·Filed 2011·Application pending·0 cites
- 3858US2006110736A1Hiv vaccine formulationsDONNELLY JOHN·Filed 2003·Application pending·0 cites
- 3956US2003170614A1Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereofFiled 2002·Application pending·0 cites
- 4056US2011052632A1Hiv polynucleotides and polypeptides derived from botswana mj4NOVARTIS VACCINES & DIAGNOSTIC·Filed 2010·Application pending·0 cites
- 4155US8226955B2Chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics that are capable of inducing neutralizing antibody responses against cryptic Env epitopesBARNETT SUSAN W·Filed 2010·Granted Jul 24, 2012·0 cites·15 claims
- 4254US2012269851A1Expression cassettes endcoding hiv-1 south african subtype c modified proteinsZUR MEGEDE JAN·Filed 2012·Application pending·0 cites
- 4353US2006057115A1Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereofZUR MEGEDE JAN·Filed 2005·Application pending·0 cites
- 4453US2011201119A1Alphavirus packaging cell linesZHAI WEIGUO·Filed 2009·Application pending·0 cites
- 4553US2011045017A1Hiv vaccine for mucosal deliveryNOVARTIS VACCINES & DIAGNOSTIC·Filed 2010·Application pending·0 cites
- 4652US2011257377A1Covalently linked complexes of HIV TAT and ENV PROTEINSBARNETT SUSAN W·Filed 2007·Application pending·0 cites
- 4752US2011110977A1Multiclade HIV VaccinesBARNETT SUSAN W·Filed 2006·Application pending·0 cites
- 4851US2007166784A1Combination approaches for generating immune responsesBARNETT SUSAN W·Filed 2004·Application pending·0 cites
- 4950US8637044B2Method of generating an immune response in a subject using fusion proteins comprising CD4 minimal modules and HIV Tat scaffold polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopesBARNETT SUSAN·Filed 2012·Granted Jan 28, 2014·0 cites·20 claims
- 5050US8168194B2Fusion proteins comprising CD4 minimal modules and human immunodeficiency virus (HIV) Tat scaffold polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopesBARNETT SUSAN·Filed 2006·Granted May 1, 2012·0 cites·15 claims
Showing the top 50 of 60 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →